Nerve monitoring: price the case supplies and correction history

Buy for the procedure and the people interpreting it

A listing headed “EMG” is not enough to specify an intraoperative nerve-monitoring service. The surgical and monitoring leads must define the intended work, required channels, patient interfaces and responsibility for interpreting the information. A console cannot substitute for that expertise or for the agreed clinical workflow.

Medtronic’s December 2022 regional description distinguishes NIM-Response 3.0, monitoring up to four nerve-muscle channels, from NIM-Neuro 3.0, up to eight. It also identifies APS electrode-dependent continuous monitoring. More channels or a named feature is useful only when the planned procedure and complete approved setup require it.

Make one complete case basket before comparing prices

List the console, patient interface, exact electrodes or tubes, stimulation probes, cables and enabled software needed for the defined case. Separate reusable components from continuing case supplies and identify their approved handling. The service needs a sustainable supply route for its actual patient range, not merely a sample accessory included with the machine.

Compare the same planned case mix and period. A lower-priced console can cost more overall if it brings higher recurring supplies or an unsupported interface. Conversely, a higher-specification platform adds little value if the team cannot obtain the required electrodes. Keep any staffing, training, processing and backup costs visible alongside the device package.

Check software and disposable notices separately

NIM Vital is a separate product from NIM 3.0, and its correction history illustrates why “software updated” needs a version and date. FDA’s 2024 false-negative-response notice described a correction to version 1.5.4. A later recall record, posted April 18, 2025, identifies increased stimulus artifact in Vital systems with version 1.6.4 or earlier and describes a manufacturer update to 1.7.5.

That later record was still shown as open when checked on October 18, 2026. Obtain applicable manufacturer correction evidence for the exact offered system; do not treat an earlier upgrade as blanket clearance or apply a Vital notice indiscriminately to a NIM 3.0 console.

Accessories need their own review. FDA’s July 2024 letter, updated that November, directs users not to use NIM Standard and Contact EMG endotracheal tubes and describes removal of all affected tubes from inventory because of blockage concerns. A package of recalled tubes has no usable value merely because it is unopened. Check exact identifiers and any proposed alternative through the responsible clinical and technical team.

Accept the whole monitoring workflow

Evaluate the offered configuration with the qualified clinical and technical team under an approved acceptance plan. Establish the required interaction with the actual theatre equipment from current instructions, including any specified accessories. Do not assume that a broad electrosurgery compatibility statement permits every generator, instrument or setup.

Agree what happens if the patient interface, cable or console fails, who provides competent support, and what temporary arrangement the service can use. A loan console is useful only if it can work with the accepted accessories and trained team. Keep an existing system when those requirements are met; replace it when required capability, correction status or continuing supply cannot be established.